About University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology
During the past decade, University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology"
#1 collaborator was "Celgene Corporation" with 2 trials as a collaborator and "Koordinierungszentrum für Klinische Studien Düsseldorf" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology
According to Clinical.Site data, the most researched conditions in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" are
"Leukemia, Myeloid, Acute" (2 trials), "Myelodysplastic Syndromes" (2 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "IDH2 Gene Mutation" (1 trials) and "IDH2 R140" (1 trials). Many other conditions were trialed in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" in a lesser frequency.
Clinical Trials Intervention Types at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology
Most popular intervention types in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" are "Drug" (3 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (2 trials), "Donor Lymphocyte Infusions" (1 trials), "Enasidenib" (1 trials), "Gene-modified (GM) T cell therapy" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology
The vast majority of trials in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" are
4 trials for "All" genders.
Clinical Trials Status at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology
Currently, there are NaN active trials in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".